Memorial Sloan Kettering AI spinout, Quest Diagnostics partner to expedite cancer diagnoses

Paige, New York City-based Memorial Sloan Kettering’s artificial intelligence spinout, teamed up with Quest Diagnostics May 25 to improve and expedite diagnoses for cancer and other diseases that need pathologic assessment.

Advertisement

Four things to know about the collaboration:

  1. Paige will use its AI capabilities to analyze pathology diagnostic data and Quest’s digitized slides to identify markers of cancer and other diseases.
  2. Paige and Quest aim to create new software products based on these insights. They also intend to license the insights to biopharmaceutical and research organizations to speed biomarker discovery, drug research and companion diagnostics.
  3. Initially, the collaboration will focus on solid tumor cancers, such as breast, prostate, lung and colorectal.
  4. Paige and Quest will share revenue for achieving certain product and commercial milestones.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.